Therapeutics Initiative: Bringing Best Evidence to Clinicians
Therapeutics Initiative: Bringing Best Evidence to Clinicians
#CPDtherapeutics
- 3.75
- 3.75
Accreditation
The University of British Columbia Division of Continuing Professional Development (UBC CPD) is fully accredited by the Committee on Accreditation of Continuing Medical Education (CACME) to provide study credits for continuing medical education for physicians. This course has been reviewed and approved by the UBC Division of Continuing Professional Development. This Group Learning course meets the certification criteria of the College of Family Physicians of Canada and has been certified by UBC CPD for up to 3.75 Mainpro+ credits. This course is an Accredited Group Learning Activity eligible for up to 3.75 MOC Section 1 credits as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada. Each physician should claim only those credits he/she actually spent in the activity.
Target Audience:
Family physicians, specialists, pharmacists, nurses, nurse practitioners, allied health professionals, residents & students
Course Format: Half-day of plenary talks highlighted by interactive Q&A time.
Broadcast starts: 0830 AM PDT
Online from Vancouver BC
Online from Vancouver BC
Agenda
8:30 Welcome and Introductions
8:45 Keynote: Legacy prescriptions for cardiovascular risk reduction (ASA, BB, ACEI, statins): what we know (and don't know)
about lifelong therapy | Dr. John Mandrola
Learning Objective
1. Understand the basics of the evidence base surrounding cardiac meds we use every day
2. Understand the challenges of external validity --or generalizability of said evidence to patients
3. In the end, the learner might come away with a heightened sense of the importance of clinical judgement and patient preferences--the two other
components of Sackett's model of EBM
9:50 Informed questions and careful observation will increase your sensitivity to adverse drug effects and help protect your patients
| Dr. Tom Perry
Learning Objectives:
1. Observing patients carefully for adverse effects of drugs
2. Eliciting drug effects with skilled questioning
3. Knowing when to measure, record, and interpret changes in vital signs caused by drugs (low standing BP example)
10:15 Stretch Break
10:30 We need to talk about tramadol | Dr. Jessica Otte
Learning Objectives:
1. Understand the unique pharmacodynamics of tramadol, and how these translate into benefits and harms
2. Compare efficacy of tramadol to other analgesics
11:00 Bupropion: the basis for its approval as an antidepressant | Dr. Cait O'Sullivan
Learning Objectives:
1. Examine whether the extended release (once a day) formulation of bupropion is superior to older formulations
2. Identify what is known about combining bupropion with other antidepressants from systematic reviews
3. Discuss whether we should consider the potential for bupropion to trigger a prescribing cascade
11:30 A safety net with several holes: Oseltamivir for influenza prophylaxis| Dr. Aaron Tejani
Learning Objectives:
1. Differentiate between influenza prophylaxis vs post-exposure prophylaxis (PEP) vs treatment as it relates to neuraminidase inhibitors
(e.g. oseltamivir)
2. List the organizational, clinician, and patient therapeutic goals/expectations when using
oseltamivir for influenza prophylaxis and PEP
3. Summarize briefly the role that unpublished data played in the understanding of oseltamivir efficacy and safety
4. Compare the evidence for oseltamivir efficacy and safety for prophylaxis and PEP vs previously defined therapeutic goals/expectations
12:00 Summarize Key Messages from the program & Closing Remarks | Dr. Aaron Tejani
12:30 Conference Ends
Key Speakers
|
|
Keynote Speaker John Mandrola, MD Cardiac electrophysiologist, Louiseville, KY. John Mandrola practices cardiac electrophysiology in Louisville KY. He writes and podcasts for the online medical news site, Medscape. In the last few years, he has participated in numerous academic collaborations. In 2019, he co-authored 19 peer-reviewed articles. His research topics range widely, from electrophysiology to outcomes and meta-research. His hobbies include running, cycling, hiking and reading. John has been an extremely popular and lively faculty member on previous visits to TI courses in Vancouver and Kimberley, BC. |
|
|
Thomas L. Perry, MD, FRCPC. Co-Chair, Education Working Group, UBC TI; Clinical Associate Professor, Department of AP&T, UBC Tom teaches clinical pharmacology and internal medicine to UBC medical students and continuing professional development for doctors, pharmacists, NPs, nurses, or anyone else interested. His outpatient practice focuses on pharmacological treatment of chronic pain and high blood pressure and reduction of pointless or dangerous polypharmacy. He encourages use of videography to teach and learn about drugs and pathophysiology. Since Covid-19 he has been adapting to online education using Zoom - which enlivened by use of patient videos. |
|
|
Cait O’Sullivan, PharmD. Pharmacist, Education and Drug Assessment Working Groups, UBC TI Cait O’Sullivan has a clinical pharmacy background in acute general medicine, long-term care, and community practice. She received a Bachelor of Arts from the University of New Brunswick (Honours, Medical Anthropology), a Bachelor of Science in Pharmacy from Dalhousie University, and a Doctor of Pharmacy Degree from the University of Washington. Cait has a research interest in the drug approval process and clinical practice guideline methodology. |
|
|
Jessica Otte, MD, CCFP. Educational Outreach & Family Practice Liaison, UBC TI;Clinical Assistant Professor, Department of Family Practice, UBC Dr. Jessica Otte is a family physician in Nanaimo, BC. She has always been passionate about helping patients find the right health care according to the evidence and their needs and values, and she practices this daily with a focus on care of the elderly and palliative care. Dr Otte is deeply engaged in sharing this approach through continuing medical education, policy and medical leadership work, an active social media presence (@LessIsMoreMed), and teaching family practice residents. |
|
|
Aaron M. Tejani, BSc.(Pharm), PharmD. Researcher and Educator, Education and Drug Assessment Working Group, UBC TI Aaron is a researcher/educator with the Therapeutics Initiative, a clinical assistant professor with the Faculty of Pharmaceutical Sciences (University of British Columbia), and Medication use evaluation pharmacist with Lower Mainland Pharmacy Services (Vancouver, BC). |
Cost
| By Sep 15 | Sep 16 - Oct 16 | After Oct 16 | |
| Delegates | $99 | $125 | $140 |
| Residents | $50 | $55 | $60 |
| Students | $25 | $30 | $35 |
All fees are in Canadian dollars. Fees are subject to 5% GST.
Fees include: access to the live virtual event, all available materials
Cancellations and RefundsCancellations: No refunds or transfers, unless you cancel in writing to cpd.info@ubc.ca by Oct 11, 2020. A $25.00 processing fee will apply.
Cancellations by the organizers: The Division of Continuing Professional Development reserves the right to cancel an educational program thirty (30) calendar days prior to the course date. Each registrant will be notified by email, followed by a full refund.
You May Also Like
Target Audience:
Psychiatrists, Primary Care Physicians, Pharmacists, Psychologists, Nurse Practitioners, Psychiatric Nurses, and Social Workers
- 6.5
- 6.5
Date: Sep 25, 2020
Location:
Broadcast starts: 0800 PDT
Online from Vancouver British Columbia
Canada Target Audience:
BCPA Members, psychiatrists, residents & students
- 4.0
Date: Nov 21, 2020
Location:
Conference starts 0900 AM
Online from Vancouver British Columbia
Canada